共查询到20条相似文献,搜索用时 0 毫秒
1.
2.
3.
4.
5.
《Saudi Pharmaceutical Journal》2016,24(5):563-570
Background: The pharmaceutical care and ‘extended’ roles are still not practiced optimally by community pharmacists. Several studies have discussed the practice of community pharmacy in the UAE and have shown that most community pharmacists only counsel patients. However, UAE, has taken initiatives to allow and prepare community pharmacists to practice ‘extended’ roles. Aim of the review: The aim was to review the current roles of community pharmacists in Abu Dhabi Emirate, United Arab Emirates (UAE). Objective: The objective was to encourage community pharmacists toward extending their practice roles. Methods: In 2010, Health Authority Abu Dhabi (HAAD) surveyed community pharmacists, using an online questionnaire, on their preferences toward extending their counseling roles and their opinion of the greatest challenge facing the extension of their counseling roles. Results: Following this survey, several programs have been developed to prepare community pharmacists to undertake these extended counseling roles. In addition to that, HAAD redefined the scope of pharmacist roles to include some extended/enhanced roles. Abu Dhabi Health Services (SEHA) mission is to ensure reliable excellence in healthcare. It has put clear plans to achieve this; these include increasing focus on public health matters, developing and monitoring evidence-based clinical policies, training health professionals to comply with international standards to deliver world-class quality care, among others. Prior to making further plans to extend community pharmacists’ roles, and to ensure the success of these plans, it is imperative to establish the views of community pharmacists in Abu Dhabi on practicing extended roles and to gain understanding and information on what pharmacists see as preferred change strategies or facilitators to change. Conclusions: In an attempt to adapt to the changes occurring and to the growing needs of patients and to maximize the utilization of community pharmacists’ unique structured strategies are needed to be introduced to the community pharmacy profession. 相似文献
6.
7.
8.
The authors set out to describe the possible impact of the continuing education activities of the Community Pharmacy Section (CPS) of the International Pharmaceutical Federation (FIP) on the profession in the period from 1980 to 2002 (approximately the last two decades of the 20th century) by reviewing and interpreting documents of the Community Pharmacy Section of the International Pharmaceutical Federation. The educational activities of the CPS have resulted in a high level of satisfaction among the participants. The CPS has also coordinated international practice research and the dissemination of the concept of pharmaceutical care. Additionally, the section's activities have informed the members of national pharmaceutical associations about new concepts, and stimulated projects on the added value of pharmacy. There are reasons to believe that the activities have created agents of change. It seems that the activities of the section have had some effect, although the exact impact remains difficult to measure because no structured evaluation method has been applied from the beginning of the continuing education activities. 相似文献
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
Suzanne Nielsen Michala Kowalski Pene Wood Sarah Larney Raimondo Bruno Marian Shanahan Simon Lenton Paul Dietze Traci Green Bridin Murnion Alison Ritter 《Research in social & administrative pharmacy》2019,15(8):1047-1055
BackgroundIncreases in opioid use and related harms such as mortality are occurring in many high income countries. Community pharmacists are often in contact with patients at risk of opioid-related harm and represent an ideal point for intervention. Best practice in monitoring opioid-related outcomes involves assessing analgesia, pain functioning, mood, risks and harms associated with opioid use. Community pharmacists are well-placed to undertake these tasks.ObjectivesOur pilot study will test the implementation of a computer-facilitated screening and brief intervention (SBI). The SBI will support pharmacist identification of opioid-related problems and provide capacity for brief intervention including verbal reinforcement of tailored information sheets, supply of naloxone and referral back to the opioid prescriber. The SBI utilises software that embeds study procedures into dispensing workflow and assesses opioid outcomes with domains aligned with a widely accepted clinical framework.MethodsWe will recruit and train 75 pharmacists from 25 pharmacies to deliver the Routine Opioid Outcome Monitoring (ROOM) SBI. Pharmacists will complete the SBI with up to 500 patients in total (20 per pharmacy). Data will be collected on pharmacists’ knowledge and confidence through pre- and post-intervention online surveys. Data on feasibility, acceptability and implementation outcomes, including naloxone supply, will also be collected.Project impactOur study will examine changes in pharmacists’ knowledge and confidence to deliver the SBI. Through the implementation pilot, we will establish the feasibility and acceptability of a pharmacist SBI that aims to improve monitoring and clinical management of patients who are prescribed opioids. 相似文献
19.
Susan J. Semple Elizabeth Hotham Deepa Rao Karen Martin Caroline A. Smith Geraldine F. Bloustien 《Pharmacy World & Science》2006,28(6):366-373
Objective To determine, by surveying Australian community pharmacists, the perceived barriers to the provision of information about
complementary and alternative medicines (CAMs) and suggestions for overcoming them.
Method Anonymous, self-administered survey sent to a random sample of 701 pharmacists registered in three states of Australia in
2004.
Main outcome measure Pharmacists’ perceived barriers to the provision of information about CAMs.
Results A total of 344 questionnaires were returned by pharmacists (49% response) of which 211 (30%) were currently practising in
community pharmacy. Ninety-five percent of surveyed community pharmacists indicated that they personally received enquires
about CAMs, with fewer than 15% reporting they were “very confident” in answering queries about safety, interactions or benefits
of CAMs. Frequently used CAM information sources were those from manufacturers and distributors, professional newsletters
and journals and textbooks. Pharmacists’ perceived barriers to the provision of CAM information included a lack of suitable
training (most training was informal), deficiencies in available information sources, a lack of managerial support, the need
for regulatory changes, consumer beliefs about CAM safety and time constraints due to competing demands in daily practice.
Pharmacists proposed improvements to overcome these barriers including improvements to training.
Conclusion There is scope for pharmacy professional organisations and educational institutions to further support pharmacists in their
practice through providing information on the best information sources available and training that meets the needs of undergraduate
students, pharmacists and other pharmacy staff. There is a need to examine regulatory requirements concerning the provision
of product information with CAMs in Australia and to implement mechanisms for increasing consumer awareness of regulatory
procedures for these medicines. 相似文献
20.
《Saudi Pharmaceutical Journal》2023,31(9):101746
IntroductionDrug-related problems (DRPs) are events or circumstances involving drug therapy that actually or potentially interferes with desired health outcomes.ObjectivesTo assess community pharmacists’ knowledge and practice regarding DRP-reduction services, as well as the barriers and factors associated with decreased provision of these services.MethodsThis cross-sectional study utilized a validated questionnaire to assess pharmacists’ knowledge, practice, and barriers to the provision of DRP-reduction services in the community pharmacy setting. Binary regression model was used to assess the variables associated with the practice of DRP-reduction services.ResultsA total of 412 pharmacists participated in the study. The pharmacists demonstrated strong knowledge but inadequate practice of DRP-reduction services. The most reported DRPs were inappropriate combination of drugs, or drugs and herbal medications, or drugs and dietary supplements (52.4%), patients’ inability to understand instructions properly (46.1%), inappropriate drug according to guidelines (43.7%), and too high dose (40.3%). The most common barriers to these services were increased workload (60.5%), limited time (53.2%), and lack of good communication skills (49.8%). The presence of a counselling area in the pharmacy increased the practice of DRP-reduction services (OR: 3.532, 95%Cl: 2.010–5.590, P < 0.001), while increased weekly working hours (OR: 0.966, 95%Cl: 0.947–0.986), P < 0.01) and serving < 10 patients daily (OR = 0.208, 95%Cl: 0.072–0.601, P < 0.01) decreased it.ConclusionsCommunity pharmacists’ practice of DRP-reduction services showed a scope for improvement. Future pharmaceutical care initiatives should increase the number of personnel working in the pharmacy and provide them with opportunities for continued education and training in order to improve the provision of DRP services and optimize patients’ outcomes. 相似文献